The strong genetic association identified between LRRK2 mutations and Parkinson’s disease has captured the attention of the research community [5], [32], with much interest focusing on whether LRRK2 modulation will be a viable strategy for treating the disease [33]. Here, LRRK2 is linked to Parkinson disease.